Skip to main content
. 2017 Aug 22;10:201. doi: 10.1186/s13068-017-0888-8

Table 6.

Characterization of PHA produced in the accumulation stage of Trial 2 compared with commercial PHA88/12

Products HB/HVa (molar ratio) Mwb (kDa) Polydispersity Rhc (nm) a d logK d
Commercial reference—PHA88/12 90/10 2∙105 1.3 14 0.70 −3.8
Extracted PHA from Trial 2 53/47 8∙105 1.4 29 0.65 −3.4

aMolar ratio such as detected by NMR

bMolecular weight distribution determined by GPC-TDA

cHydrodynamic Radius determined by GPC-TDA

dMark–Houwink parameters a and logK